Hypopharyngeal cancer pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
*''[[Cyclin D1]]''
*''[[Cyclin D1]]''
*''[[TP53]]''
*''[[TP53]]''
*''[[c-erbB2]]'' related to a lower risk of distant metastasis


==Associated Diseases==
==Associated Diseases==

Revision as of 14:51, 11 January 2019

Hypopharyngeal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypopharyngeal Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiogram or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypopharyngeal cancer pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypopharyngeal cancer pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypopharyngeal cancer pathophysiology

CDC on Hypopharyngeal cancer pathophysiology

Hypopharyngeal cancer pathophysiology in the news

Blogs on Hypopharyngeal cancer pathophysiology

Directions to Hospitals Treating Hypopharyngeal cancer

Risk calculators and risk factors for Hypopharyngeal cancer pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Faizan Sheraz, M.D. [3]

Overview

Hypopharyngeal cancer arises from squamous cells, which are cells that are normally involved in protection of aerodigestive tract. Hypopharyngeal cancer is a rare type of malignant cancer which has delayed onset of clinical symptoms. Hypopharyngeal cancer is usually found at advanced stage and it is spread to other organs such as lungs, mediastinum,bones, brain, liver, esophagus, and thyroid gland. The metastatic invasion depends on the anatomic location of the hypopharyngeal cancer. Hypopharyngeal cancer is mostly differentiated as squamous cell carcinoma, but the undifferentiated type can be found in the pyriform sinus region. The exact pathogenesis of the hypopharyngeal cancer is not exactly understood, but the p16, cyclin D1, and TP53 gene mutations have been associated with the development of the hypopharyngeal cancer. Hypopharyngeal cancer is associated with sideropenic dysphagia and Paterson Brown Kelly syndrome. On gross pathology, flattened plaques, mucosal ulceration, and raised margins of the lesion are characteristic findings of hypopharyngeal cancer. On microscopic histopathological analysis, spindle cells, basaloid cells, and nuclear atypia are characteristic findings of hypopharyngeal cancer.

Pathophysiology

  • Hypopharyngeal cancer arises from squamous cells, which are cells that are normally involved in protection of aerodigestive tract.
  • Development of hypopharyngeal cancer is the result of multiple genetic mutations. These mutations lead to activation of oncogenes and inactivation of tumor suppression genes which ultimately results in deregulated cellular proliferation.
  • Overexpression of TP53 and Cyclin D1 will be consequence of multiple primary cancers of the hypopharynx esophagus[1]

Genetics

Genes involved in the pathogenesis of hypopharyngeal cancer include:[2][1]


Associated Diseases

Hypopharyngeal carcinoma is associated with:[2]

Gross Pathology

On gross pathology, hypopharyngeal cancer is characterized by:[2]

  • Flattened plaques
  • Raised margins of the lesion
  • Mucosal ulceration
  • Tumor spread to piriform sinus
  • Exophytic

Microscopic Pathology

On microscopic histopathological analysis, hypopharyngeal carcinoma is characterized by:[2]

References

  1. 1.0 1.1 Kohmura, Takahide; Hasegawa, Yasuhisa; Ogawa, Tetsuya; Matsuura, Hidehiro; Takahashi, Masakatsu; Yanagita, Noriyuki; Nakashima, Tsutomu (1999). "Cyclin D1 and p53 Overexpression Predicts Multiple Primary Malignant Neoplasms of the Hypopharynx and Esophagus". Archives of Otolaryngology–Head & Neck Surgery. 125 (12): 1351. doi:10.1001/archotol.125.12.1351. ISSN 0886-4470.
  2. 2.0 2.1 2.2 2.3 Helliwell TR (February 2003). "acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx". J. Clin. Pathol. 56 (2): 81–5. PMC 1769882. PMID 12560383.

Template:WH Template:WS